What is Cupron?
Cupron, Inc. operates at the intersection of material science and public health, specializing in the development of copper-based antimicrobial technologies. By embedding copper compounds directly into polymers, the company creates finished products that retain their efficacy over time, resisting the degradation common in topically-applied solutions. This durable, integrated approach allows Cupron to serve a wide array of verticals, including healthcare facilities seeking to reduce pathogen transmission, consumer goods manufacturers, and industrial entities requiring long-term surface protection. The company's ability to maintain the integrity of its antimicrobial properties through repeated use distinguishes it from traditional chemical coatings, establishing a strong competitive moat in the material innovation landscape.
How much funding has Cupron raised?
Cupron has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cupron
PPP
Public-Private Partnership
What's next for Cupron?
With this latest round of backing, Cupron is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The company is expected to focus on scaling its manufacturing partnerships to meet the rising demand for integrated antimicrobial materials in the healthcare and defense sectors. By leveraging this capital, Cupron aims to solidify its market leadership, potentially exploring new polymer applications and expanding its intellectual property portfolio. The strategic focus will likely shift toward optimizing supply chain efficiencies and broadening its footprint in international markets where demand for advanced infection control solutions is reaching a critical inflection point.
See full Cupron company page
